SCHEMBL4339392

SCHEMBL4339392

O=Cc1ccc(F)c(CO)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.44
HPGD P15428 2/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 1/20 0.44
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 1/20 0.42
PTGS2 P35354 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
CYP1A2 P05177 1/20 0.38
NPC1 O15118 1/20 0.37
HSD17B10 Q99714 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
FDPS P14324 1/20 0.37
ALDH5A1 P51649 2/20 0.37
ABAT P80404 2/20 0.37
KIF11 P52732 1/20 0.36
AOX1 Q06278 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27830205 0.85 KDM4E (0.39) ALDH1A1HPGDMEN1POLBKMT2A
SCHEMBL27453852 0.84 ALDH1A1 (0.43) ALDH1A1HPGDMEN1POLBKMT2A
SCHEMBL3035961 0.82 ALDH1A1 (0.45) ALDH1A1HPGDMEN1POLBKMT2A
SCHEMBL27688344 0.82 ALDH1A1 (0.42) ALDH1A1HPGDMEN1POLBKMT2A
SCHEMBL29953151 0.82 ALDH1A1 (0.45) ALDH1A1HPGDMEN1POLBKMT2A
SCHEMBL2601956 0.81 KDM4E (0.46) ALDH1A1HPGDRAB9AKDM4EPTGS2
SCHEMBL12484917 0.80 ALDH1A1 (0.41) ALDH1A1HPGDMEN1POLBKMT2A
SCHEMBL2679167 0.80 ALDH1A1 (0.42) ALDH1A1HPGDMEN1POLBKMT2A
SCHEMBL17508767 0.79 SRC (0.44) ALDH1A1HPGDMEN1POLBKMT2A
SCHEMBL4371754 0.78 KDM4E (0.59) ALDH1A1HPGDRAB9AKDM4EPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642576-B2 Heterocyclic CETP inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-02-04 US disclosed
US-20120322761-A1 HETEROCYCLIC CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-12-20 US disclosed
CN-100522944-C Carboxylic acid derivatives and salts thereof EISAI CO LTD (JP) 2009-08-05 CN disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
CN-1503774-A Carboxylic acid derivatives and salts thereof ������������ʽ���� 2004-06-09 CN disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 ALDH1A1 844/4885HPGD 2910/4885MEN1 4091/4885
US-20120322761-A1 HETEROCYCLIC CETP INHIBITORS CETP, CES1, NPC1 ALDH1A1 2353/4885HPGD 2279/4885MEN1 3823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.